Catalyst Pharmaceuticals Inc (CPRX)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 851,411 772,010 706,360 646,676 471,907 413,211 443,896 407,227 375,630 333,114 267,309 246,972 237,788 223,248 209,130 197,216 192,354 174,860 131,412 117,880
Total stockholders’ equity US$ in thousands 727,632 660,941 608,655 561,412 387,881 348,548 375,294 333,661 300,421 270,041 241,092 220,221 206,831 198,661 188,944 178,651 169,598 156,628 111,201 99,676
Financial leverage ratio 1.17 1.17 1.16 1.15 1.22 1.19 1.18 1.22 1.25 1.23 1.11 1.12 1.15 1.12 1.11 1.10 1.13 1.12 1.18 1.18

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $851,411K ÷ $727,632K
= 1.17

The financial leverage ratio of Catalyst Pharmaceuticals Inc has shown slight fluctuations over the period analyzed. The ratio ranged from 1.10 to 1.25 during the period from March 31, 2021, to December 31, 2024. The ratio indicates that the company's debt level relative to its equity has been relatively stable, with a moderate trend towards higher leverage in the more recent quarters. A financial leverage ratio above 1 indicates that the company relies more on debt financing than equity financing. It is important to note that while moderate leverage can amplify returns, it also increases financial risk and debt servicing obligations for the company. Further analysis of the company's debt structure and overall financial health would provide a more comprehensive understanding of Catalyst Pharmaceuticals Inc's leverage position.